Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$63.15 - $90.42 $286,195 - $409,783
-4,532 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$77.28 - $99.42 $350,232 - $450,571
4,532 New
4,532 $408,000
Q1 2021

May 17, 2021

SELL
$72.25 - $168.95 $120,296 - $281,301
-1,665 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$125.56 - $178.74 $209,057 - $297,602
1,665 New
1,665 $284,000
Q1 2020

May 15, 2020

SELL
$82.38 - $131.64 $612,412 - $978,611
-7,434 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$76.53 - $135.58 $568,924 - $1.01 Million
7,434 New
7,434 $959,000
Q1 2019

May 15, 2019

SELL
$106.67 - $151.68 $211,099 - $300,174
-1,979 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$97.32 - $148.76 $192,596 - $294,396
1,979 New
1,979 $216,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.7B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.